These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18510894)

  • 61. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
    Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
    AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study.
    Amponsah-Dacosta E; Rakgole JN; Gededzha MP; Lukhwareni A; Blackard JT; Selabe SG; Mphahlele MJ
    Infect Genet Evol; 2016 Sep; 43():232-8. PubMed ID: 27245151
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection.
    Fang CT; Chen PJ; Chen MY; Hung CC; Chang SC; Chang AL; Chen DS
    J Hepatol; 2003 Dec; 39(6):1028-35. PubMed ID: 14642622
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis.
    Naing C; Poovorawan Y; Tong KS
    BMC Infect Dis; 2018 Nov; 18(1):564. PubMed ID: 30428847
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
    Puoti M; Airoldi M; Bruno R; Zanini B; Spinetti A; Pezzoli C; Patroni A; Castelli F; Sacchi P; Filice G; Carosi G
    AIDS Rev; 2002; 4(1):27-35. PubMed ID: 11998781
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lamivudine for chronic hepatitis B and HIV co-infection.
    Carton JA; Maradona JA; Asensi V; Rodríguez M; Martínez A
    AIDS; 1999 May; 13(8):1002-3. PubMed ID: 10371189
    [No Abstract]   [Full Text] [Related]  

  • 67. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
    Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
    J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of the Hepatitis B Virus/HIV-Coinfected Patient.
    Sherman KE
    Top Antivir Med; 2015; 23(3):111-4. PubMed ID: 26518394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
    Kouanfack C; Aghokeng AF; Mondain AM; Bourgeois A; Kenfack A; Mpoudi-Ngolé E; Ducos J; Delaporte E; Laurent C
    Antivir Ther; 2012; 17(2):321-6. PubMed ID: 22290198
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
    Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tenofovir-based combination therapy for HIV/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemia.
    Childs K; Joshi D; Byrne R; Bruce M; Carey I; Agarwal K; Taylor C
    AIDS; 2013 Jun; 27(9):1443-8. PubMed ID: 23435302
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
    Lada O; Gervais A; Branger M; Peytavin G; Roquebert B; Collin G; Fraqueiro G; Moucari R; Leclerc L; Martinot-Peignoux M; Matheron S; Marcellin P
    Antivir Ther; 2012; 17(1):61-70. PubMed ID: 22267470
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reversibility of cirrhosis in HIV/HBV coinfection.
    Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
    Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection.
    Huang YS; Sun HY; Chang SY; Chuang YC; Cheng A; Huang SH; Huang YC; Chen GJ; Lin KY; Su YC; Liu WC; Hung CC
    Hepatol Int; 2019 Jul; 13(4):431-439. PubMed ID: 31177505
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.
    Malagnino V; Cerva C; Maffongelli G; Teti E; Foroghi Biland L; Cesta N; De Masi M; Stingone C; Armenia D; Svicher V; Salpini R; Andreoni M; Sarmati L
    Sci Rep; 2019 Aug; 9(1):11942. PubMed ID: 31420570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
    Levy V; Grant RM
    Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.
    Piroth L; Pol S; Lacombe K; Miailhes P; Rami A; Rey D; Loustau-Ratti V; Morlat P; Goderel I; Sene D; Rosenthal E; Carrat F; Cacoub P;
    J Hepatol; 2010 Dec; 53(6):1006-12. PubMed ID: 20800920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S
    AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.